Stephen C Farrell - Net Worth and Insider Trading
Stephen C Farrell Net Worth
The estimated net worth of Stephen C Farrell is at least $7 Million dollars as of 2024-11-29. Stephen C Farrell is the CHIEF EXECUTIVE OFFICER of Convey Health Solutions Holdings Inc and owns about 636,862 shares of Convey Health Solutions Holdings Inc (CNVY) stock worth over $7 Million. Stephen C Farrell is also the Director of Lineage Cell Therapeutics Inc and owns about 97,450 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $55,430. Details can be seen in Stephen C Farrell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen C Farrell has not made any transactions after 2021-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen C Farrell
Stephen C Farrell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen C Farrell owns 3 companies in total, including Staar Surgical Co (STAA) , Lineage Cell Therapeutics Inc (LCTX) , and Convey Health Solutions Holdings Inc (CNVY) .
Click here to see the complete history of Stephen C Farrell’s form 4 insider trades.
Insider Ownership Summary of Stephen C Farrell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STAA | Staar Surgical Co | 2016-01-01 | director |
| LCTX | Lineage Cell Therapeutics Inc | 2015-11-06 | director |
| CNVY | Convey Health Solutions Holdings Inc | 2022-10-07 | director & CHIEF EXECUTIVE OFFICER |
Stephen C Farrell Latest Holdings Summary
Stephen C Farrell currently owns a total of 2 stocks. Among these stocks, Stephen C Farrell owns 636,862 shares of Convey Health Solutions Holdings Inc (CNVY) as of June 18, 2021, with a value of $7 Million and a weighting of 99.18%. Stephen C Farrell also owns 97,450 shares of Lineage Cell Therapeutics Inc (LCTX) as of November 6, 2015, with a value of $55,430 and a weighting of 0.82%.
Latest Holdings of Stephen C Farrell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNVY | Convey Health Solutions Holdings Inc | 2021-06-18 | 636,862 | 10.51 | 6,693,420 |
| LCTX | Lineage Cell Therapeutics Inc | 2015-11-06 | 97,450 | 0.57 | 55,430 |
Holding Weightings of Stephen C Farrell
Stephen C Farrell Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen C Farrell has made a total of 1 transactions in Convey Health Solutions Holdings Inc (CNVY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Convey Health Solutions Holdings Inc is the acquisition of 45,000 shares on June 18, 2021, which cost Stephen C Farrell around $585,000.
According to the SEC Form 4 filings, Stephen C Farrell has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 50,000 shares on November 6, 2015, which cost Stephen C Farrell around $191,500.
Insider Trading History of Stephen C Farrell
- 1
Stephen C Farrell Trading Performance
GuruFocus tracks the stock performance after each of Stephen C Farrell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen C Farrell is -9.1%. GuruFocus also compares Stephen C Farrell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen C Farrell within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen C Farrell's insider trading performs compared to the benchmark.
Performance of Stephen C Farrell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.69 | | | | | |
| Relative Return to S&P 500(%) | -9.96 | | | | | |
Stephen C Farrell Ownership Network
Stephen C Farrell Owned Company Details
What does Staar Surgical Co do?
Who are the key executives at Staar Surgical Co?
Stephen C Farrell is the director of Staar Surgical Co. Other key executives at Staar Surgical Co include 10 percent owner Broadwood Partners Lp , Chief Operating Officer Warren Foust , and Chief Clinical & Regulatory, Magda Michna .
Staar Surgical Co (STAA) Insider Trades Summary
Over the past 18 months, Stephen C Farrell made no insider transaction in Staar Surgical Co (STAA). Other recent insider transactions involving Staar Surgical Co (STAA) include a net purchase of 1,985,349 shares made by Broadwood Partners Lp , a net purchase of 3,750 shares made by Aimee S Weisner , and a net purchase of 2,500 shares made by Elizabeth Yeu Lin .
In summary, during the past 3 months, insiders sold 0 shares of Staar Surgical Co (STAA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Staar Surgical Co (STAA) were sold and 1,993,764 shares were bought by its insiders, resulting in a net purchase of 1,993,764 shares.
Staar Surgical Co (STAA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Staar Surgical Co Insider Transactions
Stephen C Farrell Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen C Farrell. You might contact Stephen C Farrell via mailing address: 701 Edgewater Drive, Suite 360, Wakefield Ma 01880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
